Dainippon Sumitomo Pharma’s Chemistry Research Building, Osaka, Japan
Dainippon Sumitomo Pharma (DSP) opened a new chemistry research building in Osaka, Japan, in June 2013. The research facility is located within Sumitomo Chemical's...
Cetilistat – Investigational Drug for Obesity, Japan
Developed by Alizyme, a specialist biopharmaceutical company in collaboration with Takeda Pharmaceutical, cetilistat (ATL-962) is an experimental treatment for obesity. Cetilistat restricts pancreatic lipases...
Lipaglyn (Saroglitazar) for Treating Hypertriglycerdemia in Type II Diabetes, India
Lipaglyn (Saroglitazar) is a dual peroxisome proliferator-activated receptor (PPAR) agonist indicated for the treatment of hypertriglyceridemia in Type II diabetics. The drug was discovered...
Halaven – Treatment of Metastatic Breast Cancer, Japan
Halaven is a non-taxane drug developed by Eisai Co. for the treatment of metastatic breast cancer. In March 2010, Eisai submitted a new drug...
Wockhardt Might Be Next Acquisition Target For US Pharmaceuticals
Wockhardt Limited, an Indian pharmaceutical and biotech firm, might be a good acquisition target amidst the rising trend of mergers and acquisitions (M&A) in...
Pharmaceutical firms seek larger product-liability cover after regulatory action
Pharmaceutical companies in India are seeking larger product-liability insurance cover as they face an increase in compliance costs due to regulatory action by the...
Bayer seeks marketing authorisation of aflibercept solution for injection in Japan
Bayer Yakuhin has tendered a new application in Japan for marketing authorisation for its aflibercept solution for injection in the eye. The company submitted...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...